These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 33017522)
1. Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma. Yan Y; Pan J; Chen Y; Xing W; Li Q; Wang D; Zhou X; Xie J; Miao C; Yuan Y; Zeng W; Chen D Cancer Commun (Lond); 2020 Dec; 40(12):694-710. PubMed ID: 33017522 [TBL] [Abstract][Full Text] [Related]
2. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
3. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways. Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154 [TBL] [Abstract][Full Text] [Related]
5. Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis. Liang Y; Luo H; Zhang H; Dong Y; Bao Y Cancer Biother Radiopharm; 2018 Nov; 33(9):380-386. PubMed ID: 30235011 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth. Yan Y; Chen Y; Pan J; Xing W; Li Q; Wang Y; Gei L; Yuan Y; Xie J; Zeng W; Chen D BMC Cancer; 2022 Dec; 22(1):1248. PubMed ID: 36456906 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway. Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631 [TBL] [Abstract][Full Text] [Related]
9. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma. Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550 [TBL] [Abstract][Full Text] [Related]
10. [Dopamine receptor D1 promotes the proliferation, invasion and migration of gliomas by inhibiting cAMP signaling pathway]. Yan J; Yang R Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Dec; 34(12):1116-1121. PubMed ID: 30626479 [TBL] [Abstract][Full Text] [Related]
11. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma. Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125 [TBL] [Abstract][Full Text] [Related]
12. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483 [TBL] [Abstract][Full Text] [Related]
13. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway. Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122 [TBL] [Abstract][Full Text] [Related]
14. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target. Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213 [No Abstract] [Full Text] [Related]
15. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma. Sun F; Wang J; Sun Q; Li F; Gao H; Xu L; Zhang J; Sun X; Tian Y; Zhao Q; Shen H; Zhang K; Liu J J Exp Clin Cancer Res; 2019 Nov; 38(1):449. PubMed ID: 31684995 [TBL] [Abstract][Full Text] [Related]
16. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106 [TBL] [Abstract][Full Text] [Related]
17. SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4. Shi WK; Shang QL; Zhao YF Oncol Rep; 2022 May; 47(5):. PubMed ID: 35293598 [TBL] [Abstract][Full Text] [Related]
18. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway. Ni Q; Chen Z; Zheng Q; Xie D; Li JJ; Cheng S; Ma X Cancer Sci; 2020 May; 111(5):1500-1513. PubMed ID: 31997489 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma. Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465 [TBL] [Abstract][Full Text] [Related]
20. Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma. Wang Z; Wen P; Hu B; Cao S; Shi X; Guo W; Zhang S Cancer Cell Int; 2021 Oct; 21(1):586. PubMed ID: 34717619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]